Cargando…

Myeloid Mineralocorticoid Receptor During Experimental Ischemic Stroke: Effects of Model and Sex

BACKGROUND: Mineralocorticoid receptor (MR) antagonists have protective effects in the brain during experimental ischemic stroke, and we have previously demonstrated a key role for myeloid MR during stroke pathogenesis. In this study, we explore both model- and sex-specific actions of myeloid MR dur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frieler, Ryan A., Ray, Jessica J., Meng, He, Ramnarayanan, Sai P., Usher, Michael G., Su, Enming J., Berger, Stefan, Pinsky, David J., Lawrence, Daniel A., Wang, Michael M., Mortensen, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541615/ https://www.ncbi.nlm.nih.gov/pubmed/23316294 http://dx.doi.org/10.1161/JAHA.112.002584

Ejemplares similares

Myeloid Mineralocorticoid Receptor Deficiency Inhibits Aortic Constriction-Induced Cardiac Hypertrophy in Mice
por: Li, Chao, et al.
Publicado: (2014)

New Perspectives on Sex Steroid and Mineralocorticoid Receptor Signaling in Cardiac Ischemic Injury
por: Bienvenu, Laura A., et al.
Publicado: (2022)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Aamir, Ramsha, et al.
Publicado: (2021)

Sex-Specific Differences in Autophagic Responses to Experimental Ischemic Stroke
por: Patrizz, Anthony N., et al.
Publicado: (2021)

Sex Dimorphisms in Ischemic Stroke: From Experimental Studies to Clinic
por: Jiang, Ming, et al.
Publicado: (2020)

Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity
por: Montes-Cobos, Elena, et al.
Publicado: (2017)

Ischemic stroke: experimental models and reality
por: Sommer, Clemens J.
Publicado: (2017)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Mineralocorticoid hypertension
por: Gupta, Vishal
Publicado: (2011)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
por: MUKANGWA, Memory, et al.
Publicado: (2019)

Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
por: Clemmer, John S., et al.
Publicado: (2019)

Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
por: Mortensen, Line Aas, et al.
Publicado: (2017)

Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice
por: Manrique-Acevedo, Camila, et al.
Publicado: (2021)

Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
por: Mende, Christian W., et al.
Publicado: (2023)

Intra‐arterial combination therapy for experimental acute ischemic stroke
por: Maniskas, Michael E., et al.
Publicado: (2021)

Sex and Race‐Ethnic Disparities in Door‐to‐CT Time in Acute Ischemic Stroke: The Florida Stroke Registry
por: Polineni, Sai P., et al.
Publicado: (2021)

Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments
por: Kahle, Michael P., et al.
Publicado: (2012)

The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid‐induced impaired wound healing
por: Nguyen, Van Tuan, et al.
Publicado: (2022)

Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
por: Goncalves, Andreia, et al.
Publicado: (2022)

Genome response to tissue plasminogen activator in experimental ischemic stroke
por: Jickling, Glen C, et al.
Publicado: (2010)

Sex Differences in Ischemic Stroke Outcomes in Patients With Pulmonary Hypertension
por: Pana, Tiberiu A., et al.
Publicado: (2021)

Principal function of mineralocorticoid signaling suggested by constitutive knockout of the mineralocorticoid receptor in medaka fish
por: Sakamoto, Tatsuya, et al.
Publicado: (2016)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
por: Tezuka, Yuta, et al.
Publicado: (2022)

Sex-Specific MicroRNAs in Neurovascular Units in Ischemic Stroke
por: Florijn, Barend W., et al.
Publicado: (2021)

Mineralocorticoid receptor antagonists in cardiovascular translational biology
por: Chilton, Robert J., et al.
Publicado: (2023)

Sex Differences in Risk Profile, Stroke Cause and Outcome in Ischemic Stroke Patients With and Without Migraine
por: Linstra, Katie M., et al.
Publicado: (2021)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Inactivation of Interleukin‐4 Receptor α Signaling in Myeloid Cells Protects Mice From Angiotensin II/High Salt–Induced Cardiovascular Dysfunction Through Suppression of Fibrotic Remodeling
por: Song, Jianrui, et al.
Publicado: (2021)

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
por: Bamberg, Krister, et al.
Publicado: (2019)

Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
por: Griesler, Bruno, et al.
Publicado: (2022)

Sex-Specificity of Mineralocorticoid Target Gene Expression during Renal Development, and Long-Term Consequences
por: Dumeige, Laurence, et al.
Publicado: (2017)

Sex differences in predictors of ischemic stroke: current perspectives
por: Samai, Alyana A, et al.
Publicado: (2015)

Interaction of Sex and Diabetes on Outcome After Ischemic Stroke
por: Soriano-Reixach, Maria Montserrat, et al.
Publicado: (2018)

Sex differences and risk factors in recurrent ischemic stroke
por: Chung, Ji Yeon, et al.
Publicado: (2023)

Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes
por: Finsen, Stine H., et al.
Publicado: (2021)

Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke
por: Belayev, Ludmila, et al.
Publicado: (2010)

Cerebral collateral circulation in experimental ischemic stroke
por: Cuccione, Elisa, et al.
Publicado: (2016)

Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction
por: Igbekele, Aderonke E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q13pdmj2da9nf8i99gdp7f90rj